Literature DB >> 10776762

Pharmacogenetics and future drug development and delivery.

A D Roses1.   

Abstract

Keywords:  Biomedical and Behavioral Research; Genetics and Reproduction

Mesh：

Year:  2000        PMID： 10776762     DOI： 10.1016/S0140-6736(00)02126-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  19 in total

Review 1.  Pharmacogenetics and the future of medical practice.

Authors:  Klaus Lindpaintner
Journal:  J Mol Med (Berl)       Date:  2003-03-25       Impact factor: 4.599

2.  Pharmacogenetics and pharmacogenomics: recent developments, their clinical relevance and some ethical, social, and legal implications.

Authors:  Paul W Norbert; Allen D Roses
Journal:  J Mol Med (Berl)       Date:  2003-03       Impact factor: 4.599

3.  Pharmacogenetics and the future of medical practice.

Authors:  Klaus Lindpaintner
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

4.  Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report.

Authors:  O P Corrigan
Journal:  J Med Ethics       Date:  2005-03       Impact factor: 2.903

Review 5.  Pharmacogenetics in health-care practice.

Authors:  der Zee Anke-Hilse Maitland-van; Olaf H Klungel; Anthonius de Boer
Journal:  Pharm World Sci       Date:  2004-10

6.  Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients.

Authors:  Hakon Hakonarson; Unnur S Bjornsdottir; Eva Halapi; Jonathan Bradfield; Florian Zink; Magali Mouy; Hildur Helgadottir; Asta S Gudmundsdottir; Hjalti Andrason; Asdis E Adalsteinsdottir; Kristleifur Kristjansson; Illugi Birkisson; Thor Arnason; Margret Andresdottir; David Gislason; Thorarinn Gislason; Jeffrey R Gulcher; Kari Stefansson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

Review 7.  Pharmacogenetics of major depression: insights from level 1 of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial.

Authors:  Magnus Lekman; Silvia Paddock; Francis J McMahon
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

8.  Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages.

Authors:  Richard L Kravitz; Naihua Duan; Joel Braslow
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

Review 9.  Role of genetic testing in patients undergoing percutaneous coronary intervention.

Authors:  Jae Youn Moon; Francesco Franchi; Fabiana Rollini; Jose R Rivas Rios; Megha Kureti; Larisa H Cavallari; Dominick J Angiolillo
Journal:  Expert Rev Clin Pharmacol       Date:  2017-10-12       Impact factor: 5.045

Review 10.  Clinical pharmacology: special safety considerations in drug development and pharmacovigilance.

Authors:  Kwame N Atuah; Dyfrig Hughes; Munir Pirmohamed
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.